Some psychedelic stocks can rally after the executive order on the use of the this type of drug for mental health, Oppenheimer said.

One analyst applauded Trump’s order as an “official stamp of validation” for psychedelics.

Some psychedelic stocks can rally after the executive order on the use of the this type of drug for mental health, Oppenheimer said.

The White House psychedelics executive order accelerates research, clinical trials and "Right to Try" access for drugs like psilocybin, MDMA and ibogaine.